What are the guidelines for transitioning between different anticoagulant therapies, and how do clinicians ensure a seamless and safe switch?
Gaurav ChauhanContributor
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
When switching anticoagulants, clinicians must consider the half-life of the drugs involved. They often overlap therapies to maintain protection and monitor for bleeding and thrombotic risks.